Endo USA, Inc. Recall: Clonazepam Orally Disintegrating Tablets, USP, 0.125 mg, C-IV, Rx O
Endo USA, Inc. Recall: Clonazepam Orally Disintegrating Tablets, USP, 0.125 mg, C-IV, Rx O is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Endo USA, Inc.; Product: Clonazepam Orally Disintegrating Tablets, USP, 0.125 mg, C-IV, Rx Only, 60 tablets per carton (10 blister cards containing
| Recalling firm | Endo USA, Inc. |
|---|---|
| Product | Clonazepam Orally Disintegrating Tablets, USP, 0.125 mg, C-IV, Rx Only, 60 tablets per carton (10 blister cards containing 6 tablets each), Distributed by: PAR Pharmaceutical, Chestnut Ridge, NY 10977, NDC#: 49884-306-02 (carton), NDC #: 49884-306-52 (blisters). |
| Reason for recall | Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength. |
| Classification | Class I (most serious — reasonable probability of serious health consequences or death) |
| Status | Ongoing |
| Distribution | Nationwide in the USA |
| Recall initiated | 20241118 |
| Recall number | D-0179-2025 |
| Category | drug |
| State | PA |
| Country | United States |
$29/mo
Try RecallGuard →